Sellas Life Sciences Group Inc
Change company Symbol lookup
Select an option...
SLS Sellas Life Sciences Group Inc
BAC Bank of America Corp
INCT Incapta Inc
HAYN Haynes International Inc
MLSS Milestone Scientific Inc
IMKTA Ingles Markets Inc
III Information Services Group Inc
HVRRY Hannover Rueck SE
HVRRF Hannover Rueck SE
HNFSB Hanover Foods Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap ValueCompany profile

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system.

Closing Price
$5.15
Day's Change
-1.02 (-16.53%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.69
Day's Low
5.06
Volume
(Heavy Day)
Volume:
1,509,104

10-day average volume:
809,571
1,509,104
  • Prev Close
    6.17
  • Today's Open
    6.25
  • Day's Range
    5.06-6.69
  • Avg Vol (10-day)
    809.6K
  • Last (time)
    4:00p ET 11/15/19
  • Last (size)
    1
  • 52-Wk Range
    4.79 - 94.00
    LowHigh
  • (12/04/18 - 11/11/19)
    7.52%
  • 143.2%
  • Market Cap
    23.5M
  • Shares Outstanding
    4.6M
  • -74.72
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.3
  • 487.81
  • (% of float 10/31/19)
    31.38

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.